Changes in Uterine Expression of Leukemia Inhibitory Factor ... - BioOne

15 downloads 0 Views 1MB Size Report
ABSTRACT. The multifunctional cytokine leukemia inhibitory factor (LIF) is presumed to participate in preparing the uterus for blastocyst implantation. Increased ...
BIOLOGY OF REPRODUCTION 63, 301–307 (2000)

Changes in Uterine Expression of Leukemia Inhibitory Factor Receptor Gene During Pregnancy and Its Up-Regulation by Prolactin in the Western Spotted Skunk1 Charles Passavant,3 X. Zhao,4 S.K. Das,4,5 S.K. Dey,4 and R.A. Mead2,3 Department of Biological Sciences,3 WSU/UI Center for Reproductive Biology, University of Idaho, Moscow, Idaho 83844-3051 Departments of Molecular and Integrative Physiology4 and Obstetrics and Gynecology,5 Ralph L. Smith Research Center, University of Kansas Medical Center, Kansas City, Kansas 66160-7338 ABSTRACT

lumen) [3], and up-regulation of COX-2 gene expression [2]. In addition, some changes in uterine physiology are temporally correlated with the resumption of embryonic development (i.e., blastocyst activation). These changes include increased synthesis and secretion of uterine-specific proteins [1] one of which is leukemia inhibitory factor (LIF) [6]. A multifunctional cytokine, LIF exhibits proliferative, differentiation, survival, and cell death-initiating functions depending on the cell type involved. It has been detected at relatively high concentrations in uteri of several species at the expected time of implantation [7]. In the western spotted skunk, LIF protein first becomes detectable and LIF mRNA concentration in the uterus increases significantly at the time that blastocysts resume their development [6]. Moreover, mutation of the LIF gene results in failure of implantation in the mouse, which can be overcome by a constant infusion of LIF or by transplantation of the blastocysts to pseudopregnant, wild-type recipients [8]. The precise action of LIF in the implantation process is unknown. However, LIF is not required for embryonic development in the mouse, because mutation of the LIF receptor (LIFRb) results in implantation of LIFR2/2 blastocysts and their development to term [9]. Even so, the neonates do not survive, and they exhibit reduced bone mass and reduced numbers of astrocytes in the central nervous system [9]. Deficiencies in placental function, resulting from reduction in the fetal vascular component and accumulation of fibrin in the LIFRb placentas, are presumed to be partially responsible for the early death of these neonates, as reported by Ware et al. [9]. Based on current evidence, it appears that LIF plays an essential role in preparing the uterus for successful implantation and placentation. Currently, LIF is believed to initiate signal transduction by binding solely to the LIFR complex, which consists of two subunits. The LIFRb binds LIF, oncostatin M, or cardiotrophin-1 and then forms a heterodimer with gp130 [10]. In the absence of gp130, LIF is incapable of initiating an intracellular signal. Activation of this heterodimer complex results in activation of cytoplasmic tyrosine kinases and subsequent modification of transcription factors [11]. The LIFRb exists as a transmembrane and soluble receptor [12, 13], and the liver is the primary source of soluble LIFR, which has a molecular mass of 90 kDa and binds LIF with approximately the same affinity as the transmembrane receptor [12, 14]. The soluble receptor, which circulates in the blood, is believed to inhibit the actions of LIF [12, 14]. Placental and uterine concentrations of LIFRb mRNA increase during pregnancy in the mouse [13]. To better understand the possible role of LIF in blastocyst activation and subsequent implantation in a species that exhibits an obligate delay of implantation, we examined changes in

The multifunctional cytokine leukemia inhibitory factor (LIF) is presumed to participate in preparing the uterus for blastocyst implantation. Increased production of LIF is positively correlated with termination of embryonic diapause and preparation for implantation in the spotted skunk. This study examined changes in the expression, localization, and hormonal regulation of LIF receptor (LIFRb) gene expression in the uterus of the skunk. Changes in the uterine concentration of LIFRb mRNA during pregnancy or in response to hormones after ovariectomy were determined by Northern hybridization analysis and reverse-transcriptase polymerase chain reaction. The skunk uterus produces two LIFRb transcripts, the levels of which increase in concentration when the blastocysts resume their development but then decline somewhat during the latter stage of blastocyst activation. Ovariectomy significantly reduced uterine LIFRb expression. Estradiol and/or progesterone failed to significantly elevate LIFRb mRNA levels in ovariectomized animals. Prolactin significantly increased uterine concentrations of LIFRb mRNA to greater than those of ovariectomized controls, but these levels were not comparable to those observed during preimplantation. The LIFRb mRNA was predominately localized to stromal cells surrounding the uterine glands and in yolk sac endoderm, syncytiotrophoblast, and cytotrophoblast of postimplantation embryos.

cytokines, estradiol, implantation/early development, pregnancy, progesterone, prolactin, syncytiotrophoblast, uterus

INTRODUCTION

The western spotted skunk breeds during the fall months. Early development is continuous as the embryos traverse the oviducts, but development becomes arrested at the blastocyst stage for 200 6 20 days on entering the uterus. The uterus is small, very similar in appearance to that of an anestrous animal during this period of arrested development, and secretes very little protein [1]. Several days before implantation, the uterus undergoes a series of changes, including increased weight [2], increased luminal concentrations of an inhibitor to plasminogen activator [3], loss of estrogen and progesterone receptors from the luminal epithelium [4], increased expression of epidermal growth factor-receptor mRNA [5], increased vascular permeability (as indicated by an influx of plasma proteins into the uterine Supported in part by NICHD grants HD34247 and DHHS/NIH RR11833 to R.A.M. and HD 12304 and HD29968 to S.K. Dey 2 Correspondence. FAX: 208 885 7905; e-mail: [email protected] 1

Received: 29 December 1999. First decision: 3 February 2000. Accepted: 6 March 2000. Q 2000 by the Society for the Study of Reproduction, Inc. ISSN: 0006-3363. http://www.biolreprod.org

301

302

PASSAVANT ET AL.

uterine expression, cell localization, and hormonal regulation of LIFRb in the western spotted skunk. MATERIALS AND METHODS

Reagents

Guanidine thiocyanate, guanidine hydrochloride, buffersaturated phenol, and cesium chloride were obtained from Ameresco (Dallas, TX). Tris-HCl, Tris base, sodium citrate, and sodium hydroxide were purchased from Fisher Scientific (Pittsburgh, PA). Specific DNA primers, Taq polymerase, Superscript II, and restriction enzymes were obtained from Gibco BRL (Gaithersburg, MD). RQ1 DNase, recombinant RNasin, and random hexamers were obtained from Promega (Madison, WI). AmpliTaq Gold polymerase was obtained from Perkin-Elmer (Branchbur, NJ). MAXIscript was obtained from Ambion (Austin, TX). All radioactive isotopes were obtained from NEN-DuPont (Boston, MA), and Nytran Plus membranes were purchased from Schleicher & Schuell (Keene, NH). All other chemicals were purchased from Sigma Chemical Co. (St. Louis, MO). Animals and Experimental Treatments

Seventy-nine pregnant western spotted skunks (Spilogale putorius latifrons) that had bred in the wild were obtained from a U.S. Department of Agriculture-licensed dealer (Jerry Eckstine) in Cottage Grove, Oregon. All skunks were maintained and samples collected according to the methods described by Hirzel et al. [6]. Fifty intact females were injected with an overdose of sodium pentobarbital at various times during the preimplantation and early postimplantation periods. Blood samples were collected in heparinized vacuum tubes by cardiac puncture and then stored at 2208C until the time of hormone assay. The uterus of each animal was rapidly removed, trimmed of mesentery, and flushed with 0.05 M PBS. The blastocysts were measured with an ocular micrometer, and the diameters of the embryos or implantation sites were used to determine the stage of pregnancy [15, 16]. Flushed blastocysts with diameters of 1.1 mm or smaller were classified as delayed implanting, those measuring 1.2–1.6 mm as early activated, and those measuring 1.7 mm or greater as late activated. The uteri were rapidly frozen in liquid propane at 21968C and stored at 280oC. Twenty-nine skunks whose uteri contained delayed-implanting blastocysts were assigned to one of five treatment groups in early January 1995. All animals were anesthetized with sodium pentobarbital, bilaterally ovariectomized, and allowed to recover. Six skunks received six daily injections containing 0.5 mg of prolactin (PRL) dispersed in 5% beeswax and sesame oil beginning 3 days after ovariectomy. The remaining animals were anesthetized with ketamine 6 days after ovariectomy, and Silastic capsules, whose sizes and numbers were previously described by Hirzel et al. [6], were inserted into the interscapular region. Six females received capsules containing estradiol-17b, five received capsules containing progesterone, six received capsules containing estradiol-17b and progesterone, and six received empty capsules and daily injections of 5% beeswax and oil. Steroid treatments continued for 3 days. At the end of the treatments, blood and tissue samples were obtained as described earlier. Blood plasma was assayed for both steroids and PRL according to the methods described by Hirzel et al. [6].

RNA Isolation and cDNA Preparation

Total RNA was extracted from the uterine horns of individual animals by homogenization in guanidine thiocyanate and then separated by cesium chloride gradient centrifugation. Poly (A)1 RNA for use in Northern hybridization analysis was prepared by passing total RNA from individual animals through oligo (dT) columns. Aliquots of cDNA used in the reverse-transcriptase polymerase chain reaction (RT-PCR) assays reported here were taken from the same cDNA samples used in the report of uterine LIF gene expression by Hirzel et al. [6]. A 1-ml aliquot of each cDNA was mixed with specific primers and subjected to PCR (0.2 mM deoxyribonucleotides, 2 mM MgCl2, 0.3 mM of each primer, 1.25 U AmpliTaq Gold) to amplify skunk LIFRb (sLIFRb) sequences. Primers for synthesizing and amplifying the sLIFRb cDNA were designed to nucleotides 950 to 961 and 1703 to 1720 of the human LIFRb sequence [17]. These primers amplified a 781-base pair (bp) fragment, which was then separated by electrophoresis, cloned, and identified by sequencing in both directions. Amplification primers specific for the skunk LIFRb sequences were used in the quantitative RT-PCR assay and yielded a 405bp PCR product from the cDNA templates that coded for the extracellular domain of the LIFRb. This portion of the mRNA had 88% sequence similarity to human LIFRb and 81% and 80% similarity to mouse and rat LIFRb protein. Three uterine samples from each stage of pregnancy were amplified for LIFRb, and the identity of the PCR products were verified by automated sequencing. The construction and verification of the identity of skunk cyclophilin, which was used as an internal control, were previously reported elsewhere [6]. RT-PCR

The appropriate cycle number to ensure exponential amplification of the sLIFRb cDNA (36 cycles) was determined in preliminary PCR experiments as described previously for cyclophilin [6]. Expression of both gene products was quantified in a separate set of PCR reactions consisting of cDNA samples (n 5 5–8 per group) assayed in duplicate. Hot-start PCR was performed using 0.3 M of each primer, 0.2 mM deoxyribonucleotides, 11 m Ci [32P]deoxyadenosine triphosphate (3000 Ci/mmol) and 11 mCi [32P]deoxycytidine triphosphate (3000 Ci/mmol), 2.5 U AmpliTaq Gold, 4% dimethylsulfoxide, 2.0 mM MgCl2, 5 ml cDNA, and 2.5 ml of vendor-supplied PCR buffer. The final volume was brought to 25 ml with the addition of distilled H2O. The PCR conditions consisted of an initial incubation (11 min at 958C) followed by 36 (sLIFR) or 40 (cyclophilin) cycles (20 sec each at 948C, 528C, and 728C. The PCR products were separated on 1% agarose gels, dried, and quantified using a GS-525 Molecular Imager (BioRad Laboratories, Hercules, CA). The LIFRb expression was normalized to that of cyclophilin. Northern Hybridization Analysis

Poly(A)1 RNA was prepared from individual uteri of an additional 26 animals that contained delayed-implanting blastocysts (n 5 8), early activated blastocysts (n 5 6), activated blastocysts (n 5 5), or implantation sites ranging from 3.8–16 mm in diameter (1 to 12 days postimplantation, n 5 7). Only the uterine segments between implantation sites of the latter animals were extracted. Approximately 1.5 mg of RNA from each animal was denatured

UTERINE EXPRESSION OF LIFRb IN THE SPOTTED SKUNK

303

FIG. 2. Changes in uterine expression of LIFRb during the preimplantation period as determined by quantitative RT-PCR. Note that both RTPCR and Northern blot data (see Fig. 1) indicate that uterine expression of LIFRb significantly increases (P , 0.05) at the initial stages of blastocyst activation.

ity of the hybridization, the same blots were stripped and probed with the sLIFRb sense probe. To quantify RNA loading, the blots were stripped and probed with a mouse cRNA probe to rpL7. The major sLIFRb transcript and mouse rpL7 were quantified with the GS-525 Molecular Imager, and the data were expressed as the ratio of the two gene products. FIG. 1. Changes in steady-state gene expression of LIFRb in the uterus of the spotted skunk during various stages of pregnancy. A) One of two Northern blots of skunk uterine mRNA showing changes in two LIFR transcripts. The last three lanes contain 48-h postimplantation samples. B) Quantitative analysis of the combined data from both blots regarding the major LIFRb transcript. Note that the ratio of the 2.9-kb LIFRb:rpL7 mRNA significantly increases in uteri at the time when blastocysts resume their development. Numbers in parentheses denote the sample size. Means with different superscripts differ significantly (P , 0.05).

and separated on formaldehyde agarose gels. After transfer to nylon membranes, the RNA was cross-linked by ultraviolet (UV) radiation at 120 mJ in a Stragene 2400 UV Stratalinker. The blots were prehybridized for 4 h at 688C in 53 SSPE (13 SSPE: 10 mM sodium phosphate [pH 7.4], 1 mM EDTA, 180 mM NaCl), 4% SDS, and 100 mg/ml sheared, denatured salmon-sperm DNA. Radiolabeled ([32P]UTP, 800 Ci/mmole) sense and antisense cRNA probes of skunk LIFRb and mouse rpL7 were obtained by T3- or T7-directed RNA synthesis from plasmids containing the cloned cDNAs. The construct for the rpL7 probe has been described by Das et al. [18]. The prehybridization solutions were discarded, and fresh hybridization solution containing 1 3 106 cpm/ml of the sLIFR-antisense probe was added and then incubated (18 h at 688C). The blots were washed twice in 23 SSPE and 0.1% SDS for 30 min at room temperature, followed by two washes in 0.5 3 SSPE and 0.1% SDS for 30 min at 558C, and hybrids were then detected by autoradiography. To demonstrate specific-

In Situ Hybridization

Frozen sections (10 mm) of uteri were prepared from skunks collected during delayed implantation (n 5 3), early activation (n 5 3), late activation (n 5 3), and early (4.0– 6.8 mm or about 24–48 h) postimplantation (n 5 3). Each poly-L-lysine-coated slide contained two cross-sections of uterus from the same animal. Each slide also contained sections of uterus from animals at each stage of pregnancy. The sections were hybridized with 35S-labeled sense or antisense skunk cRNA LIFRb probes. The sections were then washed as previously described and incubated with RNase A (20 ml/m) at 378C for 20 min [19]. The RNase A-resistant hybrids were detected after 30 days of exposure to Kodak NTB-2 emulsion (Eastman Kodak, Rochester, NY). Adjacent sections were hybridized with the sense probe and served as negative controls. All slides were then stained with hematoxylin-and-eosin. Statistical Analysis

The data are expressed as the mean 6 SEM. The data sets were first examined by one-way ANOVA. Differences in the mean values among treatment groups were determined by pairwise multiple comparisons using the StudentNewman-Keuls or Mann-Whitney rank sum tests. A P value of less than 0.05 was considered to be statistically significant.

304

PASSAVANT ET AL.

FIG. 3. In situ hybridization of the LIFRb mRNA in the uterus of the spotted skunk at various stages of pregnancy with a skunk antisense cRNA probe. Bright-field (left) and dark-field (right) photomicrographs show the same sections of uteri of each sample, including uterus with blastocysts in diapause (A and B), early activation (C and D), late (fully) activated 2.1-mm blastocyst (E and F), and 48- to 72-h postimplantation (G and H). Note the increase in hybridization signals (arrowhead) localized to the uterine stroma immediately beneath the glandular epithelium at the time the blastocysts resume development. Blastocysts in this specimen measured 1.15–1.25 mm in diameter. Also note the intense hybridization signals in the yolk sac endoderm (y) and the syncyiotrophoblast- and cytotrophoblast (t) of the implanted embryo. z, Zona pellucida. Bar 5 0.42 mm.

UTERINE EXPRESSION OF LIFRb IN THE SPOTTED SKUNK

305

FIG. 4. Bright-field (A) and dark-field (B) photomicrographs showing in situ hybridization of LIFRb with a skunk sense cRNA probe in an adjacent section of the same postimplantation specimen as depicted in Figure 3H. Note the complete absence of hybridization signal when the control probe was used. t, Trophoblast; y, yolk sac; z, zona pellucida. Bar 5 0.42 mm.

RESULTS

LIFR Expression During Pregnancy

Steady-state levels of LIFR mRNA in the uteri of spotted skunks during three stages of the preimplantation and the early (1–12 days) postimplantation period were determined by Northern hybridization analysis (Fig. 1). Two major transcripts of approximately 2.0 and 2.9 kilobases (kb) were observed during all stages of pregnancy that were examined, but these transcripts were most abundant among uteri in which the blastocysts were undergoing the initial stage of activation. The major transcript (2.9 kb) was significantly less abundant (P . 0.05) during delayed implantation and in segments of uterus located between the implantation sites of early postimplantation specimens. The LIFRb mRNA was still detectable in uterine segments located be-

tween implantation sites collected on Days 10 and 12 after implantation. Changes in uterine expression of the LIFR gene during pregnancy, as determined by the RT-PCR method, are shown in Figure 2. The message was detectable but present in relatively low copy numbers during the winter months, when embryonic development was arrested. Uterine concentrations of LIFRb mRNA significantly increased (P , 0.05) at early blastocyst activation but declined during the later portion of the activation process. Cell-specific autoradiographic signals for LIFRb message were faint and restricted to the deeper portions of the stroma in uteri containing delayed-implanting blastocysts (Fig. 3, A and B). In uteri containing early activating blastocysts, moderately intense hybridization signals for LIFRb mRNA were localized predominately in the stroma immediately adjacent to the uterine glands (Fig. 3, C and D). Localization of the message was the same but less intense in uteri containing late-activated blastocysts (Fig. 3, E and F). Two 24-h and one 48-h postattachment specimens were examined. Intense hybridization signals to the LIFRb message were localized in the syncytiotrophoblast, cytotrophoblast, and yolk sac endoderm of the embryos and in the endometrial stroma surrounding the basal regions of the uterine glands (Fig. 3, G and H). Very little, or perhaps no, hybridization signals to the LIFRb were observed in the inner cell mass (ICM) of one early activated blastocyst (data not shown). Positive hybridization signals were absent in all uterine sections hybridized with sense probe (Fig. 4). Hormonal Regulation of LIFR Expression

FIG. 5. Effect of various hormone treatments on skunk uterine expression of LIFRb as determined by quantitative RT PCR. Numbers in parentheses denote the sample size. Means bearing different superscripts differ significantly (P , 0.05). Note that only PRL was able to significantly upregulate uterine expression of the LIFRb.

Ovariectomy significantly reduced the ratio of LIFRb: cyclophilin mRNA (Fig. 5) compared with that in uteri containing delayed-implanting blastocysts as depicted in Figure 2 (0.114 6 0.021 vs. 2.129 6 0.275, P , 0.05). Although all steroid treatments both significantly elevated plasma concentrations of estrogen and progesterone to within the physiological range observed during the early postimplantation period and significantly increased uterine weight to greater than that of ovariectomized controls [6], none significantly enhanced uterine expression of LIFR (Fig. 5). Injection of PRL for 6 days elevated the plasma PRL concentrations to supraphysiological levels and significantly up-regulated uterine LIFRb mRNA concentrations beyond

306

PASSAVANT ET AL.

those of ovariectomized controls (Fig. 5). However, PRL had no effect on uterine weight [6], and it failed to generate uterine concentrations of LIFRb mRNA equivalent to those observed during any phase of the preimplantation period. DISCUSSION Our data indicate that at least two transcripts of LIFRb gene of approximately 2.0 and 2.9 kb are expressed in the uterus of the spotted skunk during all stages of pregnancy that we examined. The uterus and placenta of the mouse express three transcripts of approximately 11, 4.4, and 3 kb [14]. The latter transcript codes for the soluble form of the receptor and is only detectable in the uterus during pregnancy. Two major transcripts of approximately 6 and 4.5 kb and a minor transcript of 5 kb of LIFRb have been detected in human placenta [17]. One of the transcripts observed in the skunk uterus might code for a soluble form of the skunk LIFRb. The LIFRb mRNA is present in low copy numbers in the uterine stroma of the spotted skunk during the prolonged period of delayed implantation, but it undergoes significant up-regulation precisely when the blastocysts cease diapause and resume their development. The highest ratios of LIFRb:rpL7 mRNA (2.2 and 2.3) were in animals with the earliest-activated blastocysts. The LIFRb expression remains elevated but appears to decline somewhat during the latter stages of blastocyst activation. This pattern of expression is consistent with a previous report that uterine production of LIF increases at precisely the same timepoint in pregnancy [6]. Our data indicate that LIFRb mRNA is localized in the stroma of the skunk uterus rather than in the luminal or the glandular epithelium. In this respect, our data differ from those of other studies, in which LIFRb mRNA and/or protein have been detected in the luminal and glandular epithelium of the mouse [20, 21], rabbit [22], human [23], and rhesus monkey [24]. To our knowledge, only one other study has reported the appearance of LIFRb (protein) in the uterine stroma of the mouse on Day 5 of pregnancy [21]. Localization and up-regulation of the LIFRb message in the stroma at the immediate vicinity of the skunk uterine glands during early blastocyst activation suggests that LIF, which is predominately produced by the luminal epithelium and uterine glands of the spotted skunk [6], binds to LIFRb-bearing stromal cells, which, in turn, presumably release products that directly or indirectly promote blastocyst development and/or stimulate preparation of the uterus for implantation. The LIFRb hybridization signals in the ICM of an early activated blastocyst were perhaps slightly greater than background levels. Whether LIFRb is present in the ICM of delayed-implanting or fully activated blastocysts could not be determined from our specimens, however, because the tissue sections of these blastocysts did not contain any ICM. The LIFRb mRNA was consistently absent from trophoblasts of all preimplantation skunk blastocysts. The LIFRb mRNA is present in the ICM but not in the trophoblasts of mouse blastocysts [20], and both LIFRb and gp130 mRNA are detectable by RT-PCR in human morulae and blastocysts [25, 26]. Addition of LIF to defined culture medium reportedly has a beneficial effect on the growth of human preimplantation embryos [27]. If both receptor types are present in the ICM of delayed-implanting skunk blastocysts, one of the most plausible functions of LIF would be to promote the survival of ICM cells during diapause. We observed intense autoradiographic LIFRb hybridiza-

tion signals in yolk sac endoderm, syncytiotrophoblast, cytotrophoblast, and in stromal cells surrounding the basal regions of the glands of all three postimplantation skunk embryos. However, our Northern hybridization analysis of pieces from uteri devoid of embryos (interimplantation uterine segments) from all seven postimplantation specimens revealed markedly reduced LIFRb mRNA concentrations, which were comparable to those from delayed-implantation specimens. This suggests that LIFRb mRNA concentrations are higher at implantation sites than at the rest of the uterus. Our finding of LIFRb mRNA in fetal components of the placenta, coupled with the report that LIFRb2/2 neonatal mice die presumably because of the disruption of normal placentation [9], suggests that LIF may enhance placental formation or function in the spotted skunk. Expression of the LIFRb gene has also been detected in chorionic villi of first- and second-trimester as well as term placentae and, at lower levels of expression, in the decidual tissue of humans [28]. Owczarek et al. [13] reported increased expression of LIFRb in the liver, placenta, and uterus of mice during pregnancy. However, Nichols et al. [20] reported that LIFRb transcripts were down-regulated in embryos after implantation but were abundant in decidual tissue of mice. Consequently, the specific role of LIF in placentation or placental function may differ between species, because the cells possessing LIFRb vary between species. Ovariectomy significantly decreased uterine LIFR b mRNA concentrations, as determined by RT-PCR, compared with those in uteri of intact preimplantation animals (P , 0.05). This indicates that ovarian hormones play some role in up-regulating LIFRb mRNA. However, physiological levels of estradiol, administered either alone or in combination with progesterone, that induced a significant increase in uterine weight had no effect on uterine LIFRb mRNA concentrations among ovariectomized skunks. A tendency for progesterone to up-regulate uterine LIFRb mRNA was observed, but this effect was not statistically significant (P . 0.05). Prolactin significantly (P , 0.05) increased uterine LIFRb mRNA concentrations beyond those of the ovariectomized controls, but it failed to restore concentrations to those observed in intact pregnant females. Steroids induce rapid changes in specific genes [29]. Therefore, we assumed that constant administration of steroids for 3 days would be sufficient to elicit a positive response. Eighteen or more days of daily administration of PRL are required to induce early implantation in the skunk; consequently, we administered PRL for a longer duration. We cannot rule out the possibility that failure of the various hormone treatments to elevate LIFRb mRNA to concentrations similar to that in the uteri of intact animals may relate to the duration of hormone treatment. Our data suggest that a combination of progesterone, or some other ovarian hormone, and PRL may be required to achieve maximal up-regulation of uterine LIFRb mRNA. By sequencing an 800-bp RT-PCR product, we have verified that the uterus of the spotted skunk contains mRNA coding for PRL receptors localized in the luminal and glandular epithelium as well as in the myometrium (unpublished data). In this regard, our data appear to be similar to those regarding the situation in the rabbit, in which PRL enhances uterine sensitivity to progesterone by increasing progesterone receptors and the progesterone-dependent binding of nuclear proteins to the uteroglobin gene, which further stimulates transcription of the uteroglobin gene [30, 31].

UTERINE EXPRESSION OF LIFRb IN THE SPOTTED SKUNK

In summary, our results indicate that the uterus of the spotted skunk contains mRNA coding for LIFR, and that expression of this gene is up-regulated in the stromal cells beneath the glands by ovarian hormones and PRL. Increased transcription of the LIFRb gene appears to coincide with termination of embryonic diapause and resumption of embryonic development in the blastocysts.

15. 16. 17.

ACKNOWLEDGMENT We gratefully acknowledge the technical assistance of Todd Garwood in the collection and partial analysis of the RT-PCR data.

18.

REFERENCES 1. Mead RA, Rourke AW, Swannack A. Changes in uterine protein synthesis during delayed implantation in the western spotted skunk and its regulation by hormones. Biol Reprod 1979; 21:39–46. 2. Das SK, Wang J, Dey SK, Mead RA. Spatiotemporal expression of cyclooxygenase 1 and cyclooxygenase 2 during delayed implantation and the periimplantation period in the western spotted skunk. Biol Reprod 1999; 60:893–899. 3. Fazleabas AT, Mead RA, Rourke AW, Roberts RM. Presence of an inhibitor of plasminogen activator in uterine fluid of the western spotted skunk during delayed implantation. Biol Reprod 1984; 30:311– 322. 4. Mead RA, Eroschenko VP. Changes in uterine estrogen and progesterone receptors during delayed implantation and early implantation in the spotted skunk. Biol Reprod 1995; 53:827–833. 5. Paria BC, Das SK, Mead RA, Dey SK. Expression of epidermal growth factor receptor in the preimplantation uterus and blastocyst of the western spotted skunk. Biol Reprod 1994; 51:205–213. 6. Hirzel DJ, Wang J, Das SK, Dey SK, Mead RA. Changes in uterine expression of leukemia inhibitory factor during pregnancy in the western spotted skunk. Biol Reprod 1999; 60:484–492. 7. Sharkey A. Cytokines and implantation. Rev Reprod 1998; 3:52–61. 8. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359:76–79. 9. Ware CB, Horowitz MC, Renshaw BR, Hunt JS, Liggitt D, Koblar SA, Gliniak BC, McKenna HJ, Papayannopoulou T, Thoma B, Cheng L, Donovan PJ, Peschon JJ, Bartlett PF, Willis CR, Wright BD, Carpenter MK, Davison BL, Gearing DP. Targeted disruption of the lowaffinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 1995; 121:1283–1299. 10. Pennica D, Wood WI, Chien KR. Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways. Cytokine Growth Factor Rev 1996; 7:81–91. 11. Taga T. The signal transducer gp130 is shared by interleukin 6 family of haematopoietic and neurotrophic cytokines. Ann Med 1997; 29:63– 72. 12. Layton MJ, Cross BA, Metcalf D, Ward LD, Simpson RJ, Nicola NA. A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor. Proc Natl Acad Sci U S A 1992; 89:8616–8620. 13. Owczarek CM, Layton MJ, Robb LG, Nicola NA, Begley CG. Molecular basis of the soluble and membrane-bound forms of the murine leukemia inhibitory factor receptor alpha-chain. Expression in normal, gestating and leukemia inhibitory factor nullizygous mice. J Biol Chem 1996; 271:5495–5504. 14. Chambers I, Cozens A, Broadbent J, Robertson M, Lee M, Li M, Smith A. Structure of the mouse leukaemia inhibitory receptor gene: regulated expression of mRNA encoding a soluble receptor isoform

19.

20. 21.

22. 23.

24. 25.

26.

27. 28.

29.

30. 31.

307

from an alternative 59 untranslated region. Biochem J 1997; 328:879– 888. Foresman KR, Mead RA. Duration of postimplantation in a western subspecies of the spotted skunk (Spilogale putorius). J Mammal 1973; 54:521–523. Enders AC, Schlafke S, Hubbard NE, Mead RA. Morphologic changes in the blastocyst of the western spotted skunk during activation from delayed implantation. Biol Reprod 1986; 34:423–437. Gearing DP, Thut CJ, VandenBos T, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckmann MP. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp 130. EMBO J 1991; 10:2839–2848. Das SK, Das N, Wang J, Lim H, Schryver B, Plowman GD, Dey SK. Expression of betacellulin and epiregulin genes in the mouse uterus temporally by the blastocyst solely at the site of its apposition is coincident with the ‘‘window’’ of implantation. Dev Biol 1997; 190: 178–190. Das SK, Wang X-N, Paria BC, Damm D, Abraham JA, Klagsbrun M, Andrews GK, Dey SK. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development 1194; 120:1071– 1083. Nichols J, Davidson D, Taga T, Yoshida K, Chambers I, Smith A. Complementary tissue specific expression of LIF and LIF receptor mRNAs in early mouse embryogenesis. Mech Dev 1996; 57:123–131. Yang Z-M, Le S-P, Chen D-B, Cota J, Siero V, Yasukawa K, Harper MJK. Leukemia inhibitory factor, LIF receptor, and gp130 in the mouse uterus during early pregnancy. Mol Reprod Dev 1995; 42:407– 414. Yang Z-M, Le S-P, Chen D-B, Yasukawa K, Harper MJK. Expression patterns of leukaemia inhibitory factor and gp130 in rabbit uterus during early pregnancy. J Reprod Fertil 1995; 103:249–255. Cullinan EB, Abbondanzo SJ, Anderson PS, Pollard JW, Lessey BA, Stewart CL. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation. Proc Natl Acad Sci U S A 1996; 93:3115–3120. Yang Z-M, Yue Z-P, Wei P, Harper MJK. LIF, LIFR, and GP130 in rhesus monkey uterus during the menstrual cycle and early pregnancy. Biol Reprod 1999; 60(suppl 1):118–119 (abstract 81). Charnock-Jones DS, Sharkey AM, Fenwick P, Smith SK. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocysts contains mRNA for the receptor at this time. J Reprod Fertil 1994; 101:421–426. Sharkey AM, Dellow K, Blayney M, Macnamee M, Charnock-Jones S, Smith SK. Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos. Biol Reprod 1995; 53:974–982. Dunglison QF, Barlow DH, Sargent IL. Leukaemia inhibitory factor significantly enhances the blastocyst formation rate of human embryos cultured in serum free medium. Hum Reprod 1996; 11:191–196. Kojima K, Kanzaki H, Iwai M, Hatayama H, Fujimoto M, Narukawa S, Higuchi T, Kaneko Y, Mori T, Fujita J. Expression of leukaemia inhibitory factor (LIF) receptor in human placenta: a possible role for LIF in the growth and differentiation of trophoblasts. Hum Reprod 1995; 10:1907–1911. Das SK, Tan J, Johnson DC, Dey SK. Differential spatiotemporal regulation of lactoferrin and progesterone receptor genes in the mouse uterus by primary estrogen, catechol estrogen and xenoestrogen. Endocrinology 1998; 139:2905–2915. Chilton BS, Mani SK, Bullock DW. Servomechanism of prolactin and 2 progesterone in regulating uterine gene expression. Mol Endocrinol 1988; 2:1169–1175. Kleis-SanFrancisco S, Hewetson A, Chilton BS. Prolactin augments progesterone-dependent uteroglobin gene expression by modulating promoter-binding proteins. Mol Endocrinol 1993; 7:214–223.